US Patent Issued to G2GBIO on April 15 for "Sustained-release injection comprising deslorelin, and preparation method therefor" (South Korean Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,787, issued on April 15, was assigned to G2GBIO INC. (Daejeon, South Korea).

"Sustained-release injection comprising deslorelin, and preparation method therefor" was invented by Heeyong Lee (Daejeon, South Korea), Eunyoung Seol (Daejeon, South Korea), Yongha Na (Daejeon, South Korea) and Juhan Lee (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a sustained-release injection formulation comprising biodegradable polymer microspheres containing deslorelin as an active ingredient, and a preparation method therefor. The sustained-release microsphere injection containing deslorelin, according to the pr...